Firm
Practitioners believe new AI tools at the USPTO will not replace lawyers or disrupt revenue, but instead expose where a trademark attorney’s value lies
UKIPO rejects trademark application for 'Cristiano Ronaldo Origins' following opposition by Beck Greener client in a rare case that considered actual use
Partners at both firms have voted in favour of the tie-up, which marks ‘the largest law firm merger in history’
Head of IP, Andrew Brennan, and new partner, France Delord, explain how tech provides an edge in the battle for global brand owners’ business
Sponsored
Sponsored
-
Sponsored by Liu, Shen & AssociatesWenjing Zhu of Liu, Shen & Associates explains how China’s administrative adjudication system is reshaping patent enforcement, offering faster, cost-effective, and technically expert resolutions for patentees, while preserving rights to pursue court remedies -
Sponsored by Wanhuida Intellectual PropertyMinnan (Miranda) Xie of Wanhuida Intellectual Property analyses how China’s patent authorities and courts assess second medical use inventions, with key CNIPA decisions clarifying the treatment of dosage regimens and patient subgroups in novelty determinations
-
Sponsored by InventaVítor Palmela Fidalgo of Inventa examines how Portuguese case law diverges from EU rules on acquired distinctiveness, highlighting the Pão de Rio Maior decision and its implications for trademark interpretation and consumer protection
-
Sponsored by Tilleke & GibbinsVietnam’s boom in AI-generated songs raises fundamental copyright questions, say Linh Duy Mai and Diep Thi Bich Le of T&G Law Firm LLC (TGVN), the local associate of Tilleke & Gibbins
-
Sponsored by Hanol IP & LawMin Son of Hanol IP & Law explains why the ruling by South Korea’s Intellectual Property High Court marks a key development in online patent enforcement
-
Sponsored by Becerril, Coca & BecerrilCarlos Hernández León of Becerril, Coca & Becerril outlines how Mexico’s shift from NAFTA-based patent term extensions to the new SPC regime affects patent holders, particularly in pharmaceuticals, and the strategic steps to secure additional protection
